Partneringreview 2006 - Volume 1: Company deal index provides an in depth view into the deals by company, with a full index of all the deals, including mergers, acquisitions and financings announced in 2005. A clear and easy way to see the activities of any company. Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed. Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report. When using the PDF format in Acrobat Reader, simply click on the number to move around the report. The report includes the deals announced by hundreds of companies including the top 50 biopharma: Pfizer, GlaxoSmithKline, Sanofi-Aventis, Johnson & Johnson, Merck, Novartis, AstraZeneca, Roche, Bristol-Myers Squibb, Wyeth, Abbott Labs, Eli Lilly, Amgen, Takeda, Boehringer Ingelheim, Schering-Plough, Schering AG, Bayer, Eisai, Teva, Merck KGaA, Yamanouchi, Otsuka, Novo Nordisk, Baxter, Fujisawa, Sankyo, Forest Labs, Akzo Nobel, Altana, Serono, Solvay, UCB, Genzyme, Allergan, Mitsubishi Pharma, Shionogi, Watson, IVAX, Alcon, H Lundbeck, Biogen Idec, Mylan Labs, Shire, Ono, Tanabe Seiyaku, Daiichi, Barr, Gilead Sciences, Purdue Pharma. All the year’s deals at a glance. Want to know what your competitors are doing? Want to benchmark your deals against others in your therapeutic area or see how the finances of different deal types compare? Partneringreview 2006 brings all the 2005’s deals into focus in one place. Partneringreview is a comprehensive summary of the year’s deal announcements in a clear and accessible printable format. Every deal entry includes financial information where disclosed, such as headline values and upfront and milestone payments. A new addition of an overview of financings from investors is also included in this latest edition. Pages: 1852 Table of Contents Download TOC in PDF
|
